CBD Study Published January 29, 2020
In lab tests, cannabidiol (CBD), cannabichromene (CBC), cannabinol (CBN), cannabigerol (CBG), and cannabigerolic acid (CBGA) were more effective at reducing plaque-causing oral bacteria than either Oral B or Colgate (1).
How does CBD work?
Cannabinoids have antibacterial properties which appear to be effective antibacterial agents against dental plaque-associated bacteria (2).
It has been known for some time that one of the dental care benefits of cannabinoids like CBD is their antibacterial properties. This study tests how effective cannabinoids are at killing dental plaque-associated bacteria compared to common over the counter oral hygiene products Oral B and Colgate (3).
- 6 patient groups were created based on Dutch periodontal screening index
- dental plaque samples were collected from 60 adults aged 18-45
- samples were treated with either CBG, CBD, CBC, CBN, CBGA, “Cannabite-F”, “Oral B” or “Colgate”
- samples were incubated to grow bacterial cultures
- plaque-causing bacterial colonies were counted after the incubation period (4)
Cannabinoids were more effective at reducing plaque-causing bacterial colonies than the synthetic oral care products Oral B and Colgate.
“Cannabinoids have the potential to be used as an effective antibacterial agent against dental plaque-associated bacteria. Moreover, it provides a safer alternative for synthetic antibiotics to reduce the development of drug resistance.” (5)
Interested in learning more about CBD’s antibiotic boosting potential for drug-resistant bacteria? CBD makes antibiotics 64 times more effective against antibiotic-resistant bacterial strains. See the 2020 study results here.
Video on oral care and cannabis.
Keywords: antibacterial; cannabinoids; dental plaque; oral care products; personalized dental care
Stahl V, Vasudevan K. Comparison of Efficacy of Cannabinoids versus Commercial Oral Care Products in Reducing Bacterial Content from Dental Plaque: A Preliminary Observation. Cureus. 2020;12(1):e6809. Published 2020 Jan 29. doi:10.7759/cureus.6809